Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy

Brain

Volumn 138, Issue 3, 2015, Pages 616-631

  Miller Delaney, Suzanne F C ^a   Bryan, Kenneth ^a   Das, Sudipto ^a   McKiernan, Ross C ^a   Bray, Isabella M ^a   Reynolds, James P ^a   Gwinn, Ryder ^b   Stallings, Raymond L ^a,c   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b SWEDISH MEDICAL CENTER   (United States)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

DNA methylation; Epigenetics; Long non coding RNA; microRNA; Temporal lobe epilepsy

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; LONG UNTRANSLATED RNA; MICRORNA; NEUROTRANSMITTER; OXCARBAZEPINE; PHENYTOIN; UNTRANSLATED RNA; ZONISAMIDE;

ADULT; ARTICLE; CELL DEATH; CODING ALGORITHM; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE CONTROL; GENE ONTOLOGY; GENETIC ASSOCIATION; GENETIC CODE; HIPPOCAMPAL SCLEROSIS; HUMAN; HUMAN GENOME; HUMAN TISSUE; MALE; MIDDLE AGED; PILOT STUDY; PRIORITY JOURNAL; PROMOTER REGION; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; ADOLESCENT; BIOLOGY; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HIPPOCAMPUS; IMMUNOPRECIPITATION; METABOLISM; MICRODISSECTION; PATHOLOGY; PHYSIOLOGY; SCLEROSIS; YOUNG ADULT;

ADOLESCENT; ADULT; COMPUTATIONAL BIOLOGY; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; EPILEPSY, TEMPORAL LOBE; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMMUNOPRECIPITATION; MALE; MICRODISSECTION; MICRORNAS; MIDDLE AGED; PILOT PROJECTS; PROMOTER REGIONS, GENETIC; SCLEROSIS; YOUNG ADULT;

EID: 84927976254     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu373     Document Type: Article

References (60)

1. Akbarian S, Chen RZ, Gribnau J, Rasmussen TP, Fong H, Jaenisch R, et al. Expression pattern of the Rett syndrome gene MeCP2 in primate prefrontal cortex. Neurobiol Dis 2001; 8: 784-91.
2. Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimer Dis 2012; 29: 571-88.
3. Blumcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F, Bernasconi A, et al. International consensus classification of hippocam-pal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia 2013; 54: 1315-29.
4. Boison D, Sandau US, Ruskin DN, Kawamura M Jr, Masino SA. Homeostatic control of brain function-new approaches to understand epileptogenesis. Front Cell Neurosci 2013; 7: 109.
5. Buckley PG, Das S, Bryan K, Watters KM, Alcock L, Koster J, et al. Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions. Int J Cancer 2010; 128: 2296-305.
6. Das S, Bryan K, Buckley PG, Piskareva O, Bray IM, Foley N, et al. Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene 2013; 32: 2927-36.
7. Das S, Foley N, Bryan K, Watters KM, Bray I, Murphy DM, et al. MicroRNA mediates DNA demethylation events triggered by retin-oic acid during neuroblastoma cell differentiation. Cancer Res 2010; 70: 7874-81.
8. De Preter K, Barriot R, Speleman F, Vandesompele J, Moreau Y. Positional gene enrichment analysis of gene sets for high-resolution identification of overrepresented chromosomal regions. Nucleic Acid Res 2008; 36: e43.
9. Doherty MJ, Rostad SW, Kraemer DL, Vossler DG, Haltiner AM. Neocortical gliosis in temporal lobe epilepsy: gender-based differences. Epilepsia 2007; 48: 1455-9.
10. Endres M, Meisel A, Biniszkiewicz D, Namura S, Prass K, Ruscher K, et al. DNA methyltransferase contributes to delayed ischemic brain injury. J Neurosci 2000; 20: 3175-81.
11. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010; 13: 423-30.
12. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27: 91-105.
13. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011a; 14: 1345-51.
14. Guo JU, Su Y, Zhong C, Ming GL, Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011b; 145: 423-34.
15. Henshall DC. MicroRNA and epilepsy: profiling, functions and potential clinical applications. Curr Opin Neurol 2014; 27: 199-205.
16. Henshall DC, Sinclair J, Simon RP. Relationship between seizure-induced transcription of the DNA damage-inducible gene GADD45, DNA fragmentation, and neuronal death in focally evoked limbic epilepsy. J Neurochem 1999; 73: 1573-83.
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Prot 2009; 4: 44-57.
18. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33 (Suppl): 245-54.
19. Jimenez-Mateos EM, Engel T, Merino-Serrais P, Fernaud-Espinosa I, Rodriguez-Alvarez N, Reynolds J, et al. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epi-lepticus. Brain Struct Funct 2014. Advance Access published on May 30, 2014, doi:10.1007/s00429-014-0798-5.
20. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G, et al. Silencing microRNA-134 produces neu-roprotective and prolonged seizure-suppressive effects. Nat Med 2012; 18: 1087-94.
21. Jimenez-Mateos EM, Henshall DC. Seizure preconditioning and epileptic tolerance: models and mechanisms. Int J Physiol Pathophysiol Pharmacol 2009; 1: 180-91.
22. Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, et al. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 2013; 79: 1086-93.
23. Kan AA, van Erp S, Derijck AA, de Wit M, Hessel EV, O'Duibhir E, et al. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 2012; 69: 3127-45.
24. Kin T, Ono Y. Idiographica: a general-purpose web application to build idiograms on-demand for human, mouse and rat. Bioinformatics 2007; 23: 2945-6.
25. Kobow K, Blumcke I. The methylation hypothesis: do epigenetic chro-matin modifications play a role in epileptogenesis? Epilepsia 2011; 52 (Suppl 4): 15-9.
26. Kobow K, Jeske I, Hildebrandt M, Hauke J, Hahnen E, Buslei R, et al. Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 2009; 68: 356-64.
27. Kobow K, Kaspi A, Harikrishnan KN, Kiese K, Ziemann M, Khurana I, et al. Deep sequencing reveals increased DNA methylation in chronic rat epilepsy. Acta Neuropath 2013; 126: 741-56.
28. Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism. Mol Psych 2014; 19: 862-71.
29. Lemke JR, Riesch E, Scheurenbrand T, Schubach M, Wilhelm C, Steiner I, et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 2012; 53: 1387-98.
30. Lister R, Mukamel EA, Nery JR, Urich M, Puddifoot CA, Johnson ND, et al. Global epigenomic reconfiguration during mammalian brain development. Science 2013; 341: 1237905.
31. Lubin FD. Epileptogenesis: can the science of epigenetics give us answers? Epilepsy Curr 2012; 12: 105-10.
32. Ma DK, Jang MH, Guo JU, Kitabatake Y, Chang ML, Pow-Anpongkul N, et al. Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 2009; 323: 1074-7.
33. Macaulay IC, Voet T. Single cell genomics: advances and future perspectives. PLoS Genet 2014; 10: e1004126.
34. Malas S, Postlethwaite M, Ekonomou A, Whalley B, Nishiguchi S, Wood H, et al. Sox1-deficient mice suffer from epilepsy associated with abnormal ventral forebrain development and olfactory cortex hyperexcitability. Neuroscience 2003; 119: 421-32.
35. McKiernan RC, Jimenez-Mateos EM, Bray I, Engel T, Brennan GP, Sano T, et al. Reduced mature microRNA levels in association with dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PloS One 2012; 7: e35921.
36. Miller-Delaney SF, Das S, Sano T, Jimenez-Mateos EM, Bryan K, Buckley PG, et al. Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci 2012; 32: 1577-88.
37. Miller-Delaney SF, Das S, Stallings RL, Henshall DC. Investigating gene promoter methylation in a mouse model of status epilepticus. Meth Mol Biol 2013; 1067: 87-101.
38. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007; 53: 857-69.
39. Ory B, Ramsey MR, Wilson C, Vadysirisack DD, Forster N, Rocco JW, et al. A microRNA-dependent program controls p53-in-dependent survival and chemosensitivity in human and murine squa-mous cell carcinoma. J Clin Invest 2011; 121: 809-20.
40. Pitkanen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011; 10: 173-86.
41. Qureshi IA, Mehler MF. Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis. Neurobiol Dis 2010; 39: 53-60.
42. Qureshi IA, Mehler MF. Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci 2012; 13: 528-41.
43. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6: 597-610.
44. Roopra A, Dingledine R, Hsieh J. Epigenetics and epilepsy. Epilepsia 2012; 53 (Suppl 9): 2-10.
45. Ryley Parrish R, Albertson AJ, Buckingham SC, Hablitz JJ, Mascia KL, Davis Haselden W, et al. Status epilepticus triggers early and late alterations in brain-derived neurotrophic factor and NMDA glutamate receptor Grin2b DNA methylation levels in the hippocampus. Neuroscience 2013; 248C: 602-19.
46. Sabunciyan S, Aryee MJ, Irizarry RA, Rongione M, Webster MJ, Kaufman WE, et al. Genome-wide DNA methylation scan in major depressive disorder. PLoS One 2012; 7: e34451.
47. Saini HK, Griffiths-Jones S, Enright AJ. Genomic analysis of human microRNA transcripts. Proc Natl Acad Sci USA 2007; 104: 17719-24.
48. Siegel G, Obernosterer G, Fiore R, Oehmen M, Bicker S, Christensen M, et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol 2009; 11: 705-16.
49. Sosanya NM, Huang PP, Cacheaux LP, Chen CJ, Nguyen K, Perrone-Bizzozero NI, et al. Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1. J Cell Biol 2013; 202: 53-69.
50. Tan CL, Plotkin JL, Veno MT, von Schimmelmann M, Feinberg P, Mann S, et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 2013; 342: 1254-8.
51. Tao J, Wu H, Lin Q, Wei W, Lu XH, Cantle JP, et al. Deletion of astroglial dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J Neurosci 2011; 31: 8306-19.
52. Thomas RH, Berkovic SF. The hidden genetics of epilepsy-a clinically important new paradigm. Nat Rev Neurol 2014; 10: 283-92.
53. Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009; 8: 1056-72.
54. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, et al. TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acid Res 2012; 40: D222-9.
55. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7: 31-40.
56. Wang J, Yang B, Han L, Li X, Tao H, Zhang S, et al. Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines. Cell Physiol Biochem 2013; 32: 1707-19.
57. Watson C, Nielsen SL, Cobb C, Burgerman R, Williamson B. Pathological grading system for hippocampal sclerosis: correlation with magnetic resonance imaging-based volume measurements of the hippocampus. J Epilepsy 1996; 9: 56-64.
58. Wieser HG. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 2004; 45: 695-714.
59. Williams-Karnesky RL, Sandau US, Lusardi TA, Lytle NK, Farrell JM, Pritchard EM, et al. Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis. J Clin Invest 2013; 123: 3552-63.
60. Zhu Q, Wang L, Zhang Y, Zhao FH, Luo J, Xiao Z, et al. Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 2012; 46: 420-6.